Biomaterials Market: Global Industry Analysis and Forecast (2021-2029) Trends, Statistics, Dynamics, Segment Analysis

Biomaterials Market size was valued at USD 38 Bn. in 2021 and the total Biomaterials revenue is expected to grow by 7% from 2022 to 2029, reaching nearly USD 65.3 Bn.

Biomaterials Market Overview:

Biomaterials are man-made or natural materials that are used in medical technology to enhance the function of injured tissues, bones, and organs. These biological materials are used to enhance or replace natural bodily functions in medical devices and implants. Because the body does not accept any foreign material to totally supplement its biological processes, implantable biomaterials are designed to reduce the negative immune reaction while keeping proper performance. These biomaterials interact with the biological system to achieve medical goals such as treating cardiovascular, dental, orthopedic, and neurological problems. The biomaterials market is growing owing to an increase in the elderly population, an increase in the incidence rates of cardiovascular and orthopedic problems, advancements in medical technology, and more knowledge about implanted devices. Moreover, increased government investment for R&D in the field of biomaterials, as well as increased knowledge about the benefits of biomaterials products, fuel market growth. However, the high cost of biomaterial implants and compatibility concerns are expected to limit the market growth. On the other hand, the introduction of new technologies, such as decellularized dermal matrixes for grafting and hydrogen scaffolding, as well as the introduction of new products in the fields of plastic surgery, wound healing, and neurology is expected to provide profitable opportunities for market growth during the forecast period.

Biomaterials Market Report Scope:

The report on Biomaterials provides a quantitative analysis of market size, price, M&A, demand, and supply chain, investment and expansion plans by key competitors, and predictions. Porter's five forces study explains how buyers and suppliers build supplier-buyer networks and make profit-driven decisions. The present Biomaterials Market potential is assessed through detailed analysis and segmentation. The analysis will provide investors with a full insight into the industry's future, as well as the elements likely to affect the firm favorably or adversely. The research offers a complete understanding of the market for those investors wishing to invest. This study contains scenarios for the Biomaterials Market from the past and present, along with projected market numbers. The report's thorough analysis of important competitors, including market leaders, followers, and new entrants, covers every aspect of the market. The research contains strategic profiles of the top market participants, a full examination of their key competencies, and their company-specific plans for the introduction of new products, growth, partnerships, joint ventures, and acquisitions. With its clear portrayal of competitive analysis of significant companies by product, pricing, financial condition, product portfolio, growth strategies, and regional presence in the domestic as well as the local market, the research acts as an investor's guide.Biomaterials MarketTo know about the Research Methodology:-Request Free Sample Report

Biomaterials Market Dynamics:

Market Drivers: Globally growing prevalence of Cardiovascular Diseases Cardiovascular illnesses are among the top causes of mortality worldwide. Although surgical and pharmacological therapies significantly enhance the quality of life of cardiovascular patients, less expensive and less intrusive procedures are always desirable. Both natural and manmade biomaterials show considerable promise in heart repair and regeneration. The use of injectable biomaterials reduces left ventricular dilatation, increases angiogenesis, and preserves heart function. As a result, the rising frequency of cardiovascular illnesses is expected to drive market development during the forecast period. According to CDC projections in 2019, cardiovascular disease is the leading cause of mortality in the United States, accounting for one in every four fatalities. New biomaterial breakthroughs, a growing implant device and plastic surgery industry, and growing uses of biomaterials in wound care/sports injury are some of the reasons driving the growth of this market. The increased prevalence of musculoskeletal illnesses such as arthritis, dental diseases, accidents, and other diseases or health conditions is expected to increase demand for implant devices throughout the world, boosting growth in the biomaterials market over the study's forecast period. For example, according to a December 2021 research study titled "The prevalence of rheumatoid arthritis in Spain," the estimated prevalence of rheumatoid arthritis in Spain was 0.92%, with a mean age of 60.48 years, and rheumatoid arthritis was more prevalent in women than men, and because arthritis is more common in the geriatric population, the growing global geriatric population is expected to increase the burden of arthritis. According to a March 2020 update by the World Health Organization (WHO), it is estimated that nearly 3.5 billion people worldwide suffer from oral diseases, and severe periodontal (gum) disease, which can cause tooth loss, affects almost 10% of the world's population. This could increase demand for dental implants, which would fuel biomaterials market growth. According to the International Society of Aesthetic Plastic Surgery (ISAPS) 2021 report, 10.13 million surgical operations were done worldwide in 2020, compared to 11.36 million surgical procedures the previous year. The decrease in the number of surgical procedures was caused by the COVID-19 pandemic; before, the number of plastic surgery procedures was increasing; their demand is projected to expand as the number of procedures grows, and the studied market will develop. As a result, all of the aforementioned factors are likely to promote market growth throughout the forecast period.Biomaterials MarketRecent advances in biomaterials Biomaterial Technologies aid in the development of novel efficient personal protection equipment, medication delivery systems, vaccinations, and new treatments used to prevent or cure SARS-COV-2 infection. Additionally, cell-cultured models and modified tissues aided in the investigation, testing, and development of vaccines and medicines. As a consequence of the market, various designs of a variety of diagnostics and treatment tools for the management of COVID-19 have emerged, including quick and accurate diagnostic platforms, innovative vaccinations, effective anti-viral medications, and efficient laboratory models for accessing the illness. Biomaterials have become more versatile as technology has advanced, increasing their value in sectors such as bioengineering and tissue engineering. Revenue growth in this market is driven by the introduction of smart biomaterials that interact with biological systems for a variety of biomedical applications ranging from the transfer of bioactive chemicals to the cellular functioning of created functional tissues. Companies are adopting continuous advances in innovative drug delivery systems for controlled medication release, driving market expansion. For example, in January 2019, DSM Biomedical worked with ProMed Pharma to generate revolutionary controlled-release medication implants and combination devices by combining its biomedical biomaterials with ProMed's micro molding and extrusion capabilities. In recent years, porous-coated and completely or partially porous orthopedic implants have grown in popularity. Because the porous features diminish the elastic modulus and encourage bone development surrounding the implant, this is the case. Powder metallurgy, 3-D printing, and additive manufacturing are some of the processes that might be used to create porous metallic and ceramic implants. The increasing need for smart biomaterials that generate and transmit bioelectric signals comparable to biological tissues for correct physiological functioning is projected to drive market growth. Piezoelectric scaffolds are smart materials that may be used in tissue engineering. They boost signaling pathways, which improves tissue regeneration at the affected spot. Market Restraints: Strict regulatory and clinical procedures Biomaterial devices have gone through a rigorous clinical and regulatory process to assure their efficacy and quality. The fact that most biomaterial devices are implantable is the primary reason behind this. As a result, prior to market approval, they must go through a number of clinical and regulatory processes that are both difficult and restricted, depending on their composition. This makes market participants wary about investing in this market. As a result, the aforementioned factors are projected to limit market growth over the forecast period. Biomaterials Market Opportunity: The biomaterials market in emerging nations is expected to increase significantly, during the forecast period. This is attributed primarily to these countries' growing patient populations, increasing adoption of implantable devices, growing awareness of CVDs, rising disposable income, improving healthcare infrastructure, and the presence of less stringent regulatory guidelines (in comparison to developed countries). Brazil, Russia, India, China, and South Africa (BRICS) have some of the world's fastest-growing economies. According to the World Economic Forum, these rising economies will account for one-third of global healthcare expenditure by 2020. The growing need for surgical operations, an aging population, and an increase in the frequency of target illnesses are some of the primary reasons predicted to boost demand for advanced healthcare services and revolutionary medical devices in these nations' healthcare systems. This is projected to provide prospective growth prospects for biomaterials market participants in the forecast years.

Biomaterials Market Segment Analysis:

Based on Type, Owing to the wide range of product applications, the polymer product category dominated the market in terms of revenue in 2021, with a share of 30.2%, and is likely to continue leading during the forecast period. The extensive availability of biopolymers and advanced polymers for bio-resorbable tissue fixation and other orthopedic applications is also expected to increase the segment's revenue growth. Polymeric biomaterials are a cornerstone of tissue engineering. Continuous advancements in technologies like micro-manufacturing, surface modification, drug delivery, nanotechnology, and high-throughput screening play an important role in widening the use of polymeric materials in the tissue engineering sector. Natural biomaterials are expected to develop at a rapid pace during the forecast period, owing to the product's several advantages over synthetic biomaterials in terms of biodegradability, biocompatibility, and remodeling. They are increasingly being employed to replace or restore the structure and function of damaged organs or tissues as a result of these benefits. A biosensor is an analytical instrument used to detect biomolecules or biological constituents of species created by microorganisms, such as tissues, enzymes, organelles, and so on. A bio-receptor (enzymes, antibodies, nucleic acids), a transducer (electrochemical, electrical, optical, thermal, magnetic resonance), and an electronic system that includes a signal amplifier make up the majority of the sensor.Biomaterials MarketBased on the Application, The Dental Application Segment is expected to grow the fastest. Metals, polymers, ceramics, and composites are examples of dental biomaterials. The rising prevalence of dental illnesses such as periodontal disease, tooth decay, oral cancer, halitosis, and dental caries is increasing global demand for dental implants, which is likely to drive growth in the studied market. According to the World Health Organization's March 2022 report, caries of permanent teeth affect an estimated 2.2 billion people globally, while caries of primary teeth affects 520 million children. According to the same source, the prevalence of oral disease continues to rise in most low- and middle-income countries, owing primarily to increased urbanization and changes in living conditions, which is expected to increase demand for dental implants and biomaterials, and thus the dental segment is expected to grow during the forecast period. Dental caries is a progressive infectious illness, and untreated dental caries in the senior population have a substantial influence on the quality of life of older people all over the world, which is a major driver driving the market's growth. For example, according to a research study published in the International Journal of Environmental Research and Public Health in October 2021 titled "A Systematic Review on Caries Status of Older Adults," the prevalence and incidence of caries in elderly patients are the highest when compared to other age caries prevalence of 50.5% or more in their older adult population. Untreated caries differed by region, with Asia and Africa having the highest frequency. In older persons, the prevalence of dental caries ranged from 25.2% in Australia to 99.1 % in South Africa, whereas the prevalence of root caries ranged from 8% in Finland to 74% in Brazil. This is also likely to have a substantial influence on the growth of the dentistry section. Additionally, various methods used by prominent market competitors aid in market advancement. For example, Pulpdent Corporation, dental research, and production firm situated in the Greater Boston region debuted its ACTIVA Presto dental material in January 2020. The new white dental filling material has qualities similar to natural teeth. As a result, the aforementioned variables are likely to drive category growth.

Biomaterials Market Regional Insights:

North America currently dominates the market and is expected to continue to do so during the forecast period. Because of its rising target population, high adoption of cutting-edge goods, and the presence of multiple pharmaceutical businesses, North America is expected to account for a sizable percentage of the worldwide biomaterials market. According to research issued in March 2020 by Weinstein Legal, almost 30 million children and adolescents participate in youth sports in the United States each year. According to the American Society of Plastic Surgeons (ASPS) 2020 estimate, over 2.3 million cosmetic surgery operations were done in 2020. The top five cosmetic surgical operations, according to the same source, were nose reshaping, eyelid surgery, facelift, liposuction, and breast augmentation. According to the same source, the top five reconstructive procedures performed in the United States were tumor removal (5.2 million), laceration repair (386,710), maxillofacial surgery (256,085), scar revision (263,643), and hand surgery (206,928), and because biomaterials and implants are used in cosmetic and reconstructive surgeries, the increase in these procedures is expected to drive growth in the studied market in the United States. Additionally, the existence of well-established market players, as well as strategic efforts performed by these market players, as well as ongoing new product releases, pave the way for market expansion. Noble Biomaterials announced the release of Ionic+ Durable, an Ionic+ fabric solution, in April 2021. Noble Biomaterials develops breakthrough material innovations for use in areas such as performance clothing, healthcare, industrial, and upcoming wearable technology. Similarly, Essent Biologics, a biotechnology firm, announced its establishment as a new venture in January 2021 to satisfy the growing need for human-derived biomaterials and data in the regenerative medicine research community. As a result of the aforementioned reasons, the studied market in North America is expected to increase significantly during the forecast period.

Biomaterials Market Scope: Inquire before buying

Biomaterials Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 38 Bn.
Forecast Period 2022 to 2029 CAGR:  7% Market Size in 2029: US $ 65.3 Bn.
Segments Covered: by Type • Natural Biomaterial • Metallic Biomaterial • Ceramic Biomaterial • Polymeric Biomaterial
by Application • Dental • Neurology • Cardiology • Orthopedics • Ophthalmology • Wound Care • Plastic Surgery • Other Applications
by Region North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)

Leading Players in the Biomaterials Market are:

• Celanese Corporation (US) • Lubrizol Corporation (US) • Berkeley Advanced Biomaterials (US) • Zeus Industrial Products, Inc (US) • Noble Biomaterials, Inc (US) • Dimension Inx (US) • DSM Biomedical (US) • Yulex Inc (US) • Dentsply Sirona (US) • ABK Biomedical (Canada) • Olympus Terumo Biomaterials Corp. (Japan) • Fuji Micra Inc (Japan) • Wright Medical Group N.V. (UK) • Invibio Ltd. (UK) • BASF SE (Germany) • Evonik Industries AG (Germany) • Covestro AG (Germany) • Corbion (Netherlands) • Cam Bioceramics (Netherlands) • Optics11 BV (Netherlands) • Hycail Oy (Finland) • Solvay (Belgium) • Biovotec AS (Norway) Frequently Asked Questions: 1] What are the four common biomaterials? Ans. Metals, ceramics, glass, and polymers are examples of biomaterials. 2] What are biomaterials? Ans. Biomaterials are essential in medicine, restoring function and promoting healing after damage or sickness. Biomaterials, which can be natural or synthetic, are utilized in medical applications to sustain, improve, or replace damaged tissue or biological functions. 3] How do biomaterials work? Ans. Biomaterials are substances that are intended to be put into the body in order to replace or repair damaged organs or tissues. Biomaterials frequently have unique qualities that allow them to interact with human cells, tissue, and organs without being rejected by the body. 4] How are biomaterials made? Ans. Biomaterials can be produced from nature or made in the laboratory using a number of chemical methods that include metallic components, polymers, ceramics, or composite materials. 5] Are biomaterials effective? Ans. They perform well and improve the lives of those they benefit, yet they nevertheless include a lot of mistakes. It follows that biomaterials can never be as effective as the original material, despite being effective in terms of its qualities and activities. 6] What are the advantages and disadvantages of biomaterials? Ans. Biomaterials are simple to produce and alter. Additionally, they are biodegradable, which has both benefits and drawbacks. They can leak, resulting in wear and tear, as a result of intense contact with the body. They can also take water and vital nutrients from the blood.
1. Global Biomaterials Market Size: Research Methodology 2. Global Biomaterials Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Biomaterials Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Biomaterials Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Biomaterials Market Size Segmentation 4.1. Global Biomaterials Market Size, by Type (2021-2029) • Natural Biomaterial • Metallic Biomaterial • Ceramic Biomaterial • Polymeric Biomaterial 4.2. Global Biomaterials Market Size, by Application (2021-2029) • Dental • Neurology • Cardiology • Orthopedics • Ophthalmology • Wound Care • Plastic Surgery • Other Applications 5. North America Biomaterials Market (2021-2029) 5.1. North America Biomaterials Market Size, by Type (2021-2029) • Natural Biomaterial • Metallic Biomaterial • Ceramic Biomaterial • Polymeric Biomaterial 5.2. North America Biomaterials Market Size, by Application (2021-2029) • Dental • Neurology • Cardiology • Orthopedics • Ophthalmology • Wound Care • Plastic Surgery • Other Applications 5.3. North America Semiconductor Memory Market, by Country (2021-2029) • United States • Canada • Mexico 6. European Biomaterials Market (2021-2029) 6.1. European Biomaterials Market, by Type (2021-2029) 6.2. European Biomaterials Market, by Application (2021-2029) 6.3. European Biomaterials Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Biomaterials Market (2021-2029) 7.1. Asia Pacific Biomaterials Market, by Type (2021-2029) 7.2. Asia Pacific Biomaterials Market, by Application (2021-2029) 7.3. Asia Pacific Biomaterials Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Biomaterials Market (2021-2029) 8.1. Middle East and Africa Biomaterials Market, by Type (2021-2029) 8.2. Middle East and Africa Biomaterials Market, by Application (2021-2029) 8.3. Middle East and Africa Biomaterials Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Biomaterials Market (2021-2029) 9.1. South America Biomaterials Market, by Type (2021-2029) 9.2. South America Biomaterials Market, by Application (2021-2029) 9.3. South America Biomaterials Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Celanese Corporation (US) 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Lubrizol Corporation (US) 10.3. Berkeley Advanced Biomaterials (US) 10.4. Zeus Industrial Products, Inc (US) 10.5. Noble Biomaterials, Inc (US) 10.6. Dimension Inx (US) 10.7. DSM Biomedical (US) 10.8. Yulex Inc (US) 10.9. Dentsply Sirona (US) 10.10. ABK Biomedical (Canada) 10.11. Olympus Terumo Biomaterials Corp. (Japan) 10.12. Fuji Micra Inc (Japan) 10.13. Wright Medical Group N.V. (UK) 10.14. Invibio Ltd. (UK) 10.15. BASF SE (Germany) 10.16. Evonik Industries AG (Germany) 10.17. Covestro AG (Germany) 10.18. Corbion (Netherlands) 10.19. Cam Bioceramics (Netherlands) 10.20. Optics11 BV (Netherlands) 10.21. Hycail Oy (Finland) 10.22. Solvay (Belgium) 10.23. Biovotec AS (Norway)

About This Report

Report ID 20349
Category Medical Devices
Published Date Feb 2023
Updated Date
Contact Us